全文获取类型
收费全文 | 127056篇 |
免费 | 10080篇 |
国内免费 | 3074篇 |
专业分类
耳鼻咽喉 | 1253篇 |
儿科学 | 7252篇 |
妇产科学 | 3872篇 |
基础医学 | 14069篇 |
口腔科学 | 1676篇 |
临床医学 | 14274篇 |
内科学 | 20772篇 |
皮肤病学 | 2876篇 |
神经病学 | 10780篇 |
特种医学 | 3234篇 |
外国民族医学 | 3篇 |
外科学 | 13572篇 |
综合类 | 17644篇 |
现状与发展 | 16篇 |
预防医学 | 7346篇 |
眼科学 | 2204篇 |
药学 | 6275篇 |
60篇 | |
中国医学 | 11216篇 |
肿瘤学 | 1816篇 |
出版年
2024年 | 234篇 |
2023年 | 2219篇 |
2022年 | 3503篇 |
2021年 | 6268篇 |
2020年 | 5759篇 |
2019年 | 4565篇 |
2018年 | 4634篇 |
2017年 | 4642篇 |
2016年 | 4793篇 |
2015年 | 4544篇 |
2014年 | 8924篇 |
2013年 | 9189篇 |
2012年 | 7222篇 |
2011年 | 8359篇 |
2010年 | 6483篇 |
2009年 | 6325篇 |
2008年 | 6148篇 |
2007年 | 6204篇 |
2006年 | 5609篇 |
2005年 | 4616篇 |
2004年 | 3951篇 |
2003年 | 3494篇 |
2002年 | 2382篇 |
2001年 | 2177篇 |
2000年 | 1882篇 |
1999年 | 1739篇 |
1998年 | 1463篇 |
1997年 | 1368篇 |
1996年 | 1303篇 |
1995年 | 1261篇 |
1994年 | 1063篇 |
1993年 | 948篇 |
1992年 | 864篇 |
1991年 | 666篇 |
1990年 | 625篇 |
1989年 | 511篇 |
1988年 | 517篇 |
1987年 | 467篇 |
1986年 | 407篇 |
1985年 | 521篇 |
1984年 | 438篇 |
1983年 | 269篇 |
1982年 | 352篇 |
1981年 | 313篇 |
1980年 | 257篇 |
1979年 | 216篇 |
1978年 | 136篇 |
1977年 | 108篇 |
1976年 | 87篇 |
1975年 | 42篇 |
排序方式: 共有10000条查询结果,搜索用时 156 毫秒
91.
92.
93.
94.
Takahiro Namiki Chika Takano Ryoji Aoki Quang Duy Trinh Ichiro Morioka Satoshi Hayakawa 《Congenital anomalies》2022,62(1):38-41
Congenital rubella syndrome (CRS) results from maternal rubella virus infection in early pregnancy. Abnormal neuroimaging findings have been analyzed in a small number of CRS patients in the past; however, their clinical significance has been poorly addressed. Therefore, we have investigated the neuroimaging findings of 31 patients with CRS from previous studies. The most common finding was parenchymal calcification, which was observed in 18 of 31 patients (58.1%). A multivariable logistic regression model showed that it was associated with psychomotor or mental retardation (p = 0.018), suggesting that parenchymal calcification in CRS could be a prognostic factor. 相似文献
95.
96.
97.
98.
吕聪 《中国中医药现代远程教育》2020,(1):124-126
目的研究辨证分型联合西药治疗免疫球蛋白a(Ig A)肾病的临床效果。方法选取收治的74例Ig A肾病患者,采用均衡分组法分为西药组和联合组,各37例。西药组采用氯沙坦钾片治疗,联合组辅以辨证分型治疗,治疗6个月后开展随访观察疗效。结果联合组治疗总有效率94.59%高于西药组的64.86%,联合组并发症发生率2.70%低于西药组的21.62%,联合组不良反应发生率2.70%低于西药组的24.32%,对比差异有统计学意义(P<0.05)。治疗后,联合组血肌酐高于西药组和治疗前,尿红细胞、尿蛋白指标低于西药组和治疗前,对比有统计学意义(P<0.05)。结论辨证分型联合西药治疗Ig A肾病的临床效果显著,可降低并发症及不良反应发生风险,改善其血液指标,具有较高临床推广价值。 相似文献
99.
目的探讨新诊断2型糖尿病(T2DM)常见中医证型与非酒精性脂肪肝(NAFLD)及其相关危险因素的相关性,为中西医结合治疗提供临床指导。方法选择沧州中西医结合医院门诊和病房收治的300例新诊断T2DM患者作为研究对象,根据其是否合并NAFLD分为合并NAFLD组,单纯T2DM组。记录2组一般资料,依照《糖尿病中医防治指南》对所有患者进行辨证分型,记录2组腰围、身高、体质量、体质量指数(BMI)、肝功指标[丙氨酸转氨酶(ALT)、天冬氨酸转氨酶(AST)、γ-谷氨酰转肽酶(GGT)、碱性磷酸酶(ALP)]、血脂指标(TG、TC、HDL-C、LDL-C)及血尿酸(SUA)、空腹血糖(FPG)、空腹胰岛素(FINS)、空腹C-肽(FC-P)、胰岛素抵抗指数(HOMA-IR),分析各中医证型与客观化指标的关系。结果合并NAFLD组124例,单纯T2DM组176例,2组性别、年龄比较差异无统计学意义(P均>0.05);合并NAFLD组的痰湿郁阻证占比明显高于T2DM组(P<0.05),其余分型占比组间比较差异无统计学意义(P均>0.05);合并NAFLD组的腰围、BMI、TG、TC、FC-P、HOMA-IR均显著高于T2DM组(P均<0.05),其余指标2组比较差异无统计学意义(P均>0.05);非条件Logistic回归分析显示,NAFLD的独立危险因素为BMI、TG、HOMA-IR。结论痰湿郁阻证是T2DM合并NAFLD患者的最常见证型,肥胖、胰岛素抵抗、脂质代谢紊乱是T2DM合并NAFLD患者的独立危险因素。 相似文献
100.
Xia Li Wang Junni Xie Xishao Xiang Shilong Zhang Xiaohui Chen Jianghua Han Fei 《中华肾脏病杂志》2020,36(7):497-502
Objective To observe the clinical characteristics and prognosis of patients with rapidly progressive glomerulonephritis (RPGN) caused by lupus nephritis, antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis, or primary glomerulonephritis who were treated with peritoneal dialysis (PD) and then withdrew PD because of renal recovery. Methods Data of the above patients were retrospectively analyzed. The patients were diagnosed as RPGN and received PD therapy in Kidney Disease Center, the First Affiliated Hospital, College of Medicine, Zhejiang University from February 2009 to August 2018. The patients were divided into early withdrawal group (PD time≤183 days, n=24) and late withdrawal group (PD time>183 day, n=24). The differences of clinical characteristics between the two groups were compared. The cumulative incidence of adverse events in both groups was analyzed using Kaplan-Meier curves. Cox proportional hazards model was used to analyze the risk factors influencing the prognosis of patients. Results Forty-eight RPGN patients were included. The median time of maintaining PD was 178(76, 378) days. Compared with the late withdrawal group, the patients in early withdrawal group had lower levels of urine volume, serum albumin and parathyroid hormone, and lower rates of gross hematuria and hypertension at the beginning of PD, and received higher rates of methylprednisolone impulse, combined immunosuppressive agents, and hemodialysis or continuous renal replacement therapy (all P<0.05). At the time of PD withdrawal, the levels of serum creatinine, serum calcium, serum albumin and parathyroid hormone in the early withdrawal group were significantly lower than those in the late withdrawal group (all P<0.05). The Kaplan-Meier curves showed that there was no significant difference in the cumulative survival of patients in both groups (log-rank test χ2=3.485, P=0.062). Cox regression analysis revealed serum creatinine≥209 μmol/L at the time of PD withdrawal was an independent risk factor for poor prognosis (HR=5.253,95%CI 1.757-15.702, P=0.003). Conclusions PD can be used for RPGN patients caused by lupus nephritis, ANCA-associated vasculitis and primary nephritis. Serum creatinine≥209 μmol/L at the time of PD withdrawal is an independent risk factor for poor prognosis. 相似文献